Document is current
Any future updates will be listed below
-
Authors
Kaufman, Alexandra M.
Silver, Benjamin
Donnianni, Roberto A.
Aguilar, Carlos https://orcid.org/0000-0002-4655-1778
Niu, Lingzi
Johnson, Daniel
Bullen, Anwen https://orcid.org/0000-0002-6705-5263
Corona, Alma
van Soldt, Benjamin J.
Vora, Nilay https://orcid.org/0000-0002-2265-5580
Batista, Gervasio
Cortes-Burgos, Luz
Copeland, Jacqueline
Fallah, Elika
Zhang, Norman
Lehmkuhl, Marina
Cancelarich, Sarah
Campos, Kara
Di Battista Miani, Daniela
Mumphrey, Jaylen
Croll, Susan D.
Walls, Johnathon R.
Germino, Mary
Bowl, Michael R. https://orcid.org/0000-0001-7971-445X
Drummond, Meghan C.
Dawson, Sally J. https://orcid.org/0000-0002-4421-2043
-
Funding
Funding for this research was provided by:
Royal College of Surgeons of England (Duveen Fellowship in Otology)
Dunhill Medical Trust (RPGF2002\189 and CER\91)
Action on Hearing Loss (F98)
RCUK | Medical Research Council (MC_UP_1503/2 and MR/X004597/1)
- License Information
-
More Information
Article History
Received: 9 January 2025
Accepted: 28 November 2025
First Online: 17 December 2025
Competing interests
: A.M.K., R.A.D., D.J., A.C., B.J.vS., N.V., G.B., L.C.B., J.C., E.F., N.Z., M.L., S.C., K.C., D.D.B.M., J.M., S.D.C., J.R.W., M.G., and M.C.D. are all employees of Regeneron Pharmaceuticals, Inc. B.S., C.A., L.N., A.B., M.R.B., and S.J.D. have no competing interest.
